Tok, S.
Maurin, H.
Delay, C.
Crauwels, D.
Manyakov, N. V.
Van Der Elst, W.
Moechars, D.
Drinkenburg, W. H. I. M.
Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (765549)
H2020 Marie Skłodowska-Curie Actions (765549)
Article History
Received: 30 December 2021
Accepted: 19 April 2022
First Online: 11 May 2022
Competing interests
: The authors declare that they are working for Janssen Pharmaceutica NV. The authors declare no other commercial or financial relationships that could be construed as a potential conflict of interest.